Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations. | Molecules | 2023 | 37630311 | PubTator, text mining | PubMed |
| Expression of Prostaglandin Genes and β-Catenin in Whole Blood as Potential Markers of Muscle Degeneration. | Int J Mol Sci | 2023 | 37629065 | PubTator, text mining | PubMed |
| BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. | Cancers (Basel) | 2023 | 37627054 | PubTator, text mining | PubMed |
| Targeting Conserved Pathways in 3D Spheroid Formation of Diverse Cell Types for Translational Application: Enhanced Functional and Antioxidant Capacity. | Cells | 2023 | 37626861 | PubTator, text mining | PubMed |
| In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood. | Front Cell Dev Biol | 2023 | 37601099 | PubTator, text mining | PubMed |
| Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent. | Front Pharmacol | 2023 | 37601048 | PubTator, text mining | PubMed |
| Protective Effects of Long-Term Usage of Cyclo-Oxygenase-2 Inhibitors on Colorectal Cancer in Genetically Predisposed Individuals and Their Overall Effect on Prognosis: A Systematic Review. | Cureus | 2023 | 37588311 | PubTator, text mining | PubMed |
| Is prophylactic anti-convulsive treatment necessary in subdural hematomas? | Ulus Travma Acil Cerrahi Derg | 2023 | 37563902 | PubTator, text mining | PubMed |
| Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. | Cancer Res Commun | 2023 | 37559947 | PubTator, text mining | PubMed |
| Novel pharmacological approaches in abdominal aortic aneurysm. | Clin Sci (Lond) | 2023 | 37559446 | PubTator, text mining | PubMed |
| Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis. | Front Pharmacol | 2023 | 37547337 | PubTator, text mining | PubMed |
| Platelet-rich plasma in the pathologic processes of tendinopathy: a review of basic science studies. | Front Bioeng Biotechnol | 2023 | 37545895 | PubTator, text mining | PubMed |
| Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities. | Lipids Health Dis | 2023 | 37537607 | PubTator, text mining | PubMed |
| MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction. | Front Immunol | 2023 | 37533852 | PubTator, text mining | PubMed |
| Multiple Injections of Adipose-Derived Stem Cells Improve Graft Survival in Human-to-Rat Skin Xenotransplantation through Immune Modulation. | Tissue Eng Regen Med | 2023 | 37531072 | PubTator, text mining | PubMed |
| Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion. | Cancer Res Commun | 2023 | 37529399 | PubTator, text mining | PubMed |
| The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders. | Exp Biol Med (Maywood) | 2023 | 37515545 | PubTator, text mining | PubMed |
| Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas. | Cancers (Basel) | 2023 | 37509325 | PubTator, text mining | PubMed |
| Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer-Looking Back and Forward. | Cells | 2023 | 37508575 | PubTator, text mining | PubMed |
| Off-Label Use of Crisdesalazine (GedaCure) in Meningoencephalitis in Two Dogs. | Vet Sci | 2023 | 37505843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=11